SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dogelon Mars

Dogelon Mars is trending as investors debate the project's long-term viability versus its status as a legacy meme coin, with the community actively tracking potential exchange listings and social media activity. Participants are polarized between those waiting for a major token burn or market breakout and others who view the asset as a speculative gamble compared to leading cryptocurrencies.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is facing significant market volatility as investors weigh disappointing early-stage cystic fibrosis clinical data against the company's strong cash position and pipeline potential. Community sentiment remains polarized, with some investors viewing the sharp price decline as an overreaction and a buying opportunity, while others are concerned about the lack of near-term catalysts and long-term commercial viability.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

Pepe is currently drawing significant attention from investors as it navigates market volatility, with community members actively discussing accumulation strategies and potential price rebounds. The discourse is heavily fueled by speculative interest in meme coin cycles, comparisons to other frog-themed tokens, and optimistic outlooks on institutional liquidity as market participants position for future potential gains.

Bank of Montreal engages in the provision of banking and financial services to individuals and institutions. It operates through the following segments: Canadian Personal and Commercial Banking (Canadian P&C), United States Personal and Commercial Banking (U.S. P&C), BMO Wealth Management, BMO Capital Markets, and Corporate Services. The company was founded by Robert Armour, John C. Bush, Austin Cuvillier, George Garden, Horatio Gates, James Leslie, George Moffatt, John Richardson and Thomas A. Turner on June 23, 1817 and is headquartered in Toronto, Canada.

Bank of Montreal - MicroSectors Gold Miners -3X Inverse Leveraged ETNs

GDXD is capturing significant trader attention as a high-volatility play for those seeking to hedge or speculate against the relentless upward momentum in precious metals. The community is actively debating the timing of a potential gold correction, with many traders using it as a tactical tool to capitalize on daily swings while others warn of the risks associated with long-term decay in leveraged inverse ETFs.

Stack Capital Group, Inc. operates as an investment holding company. It engages in making investments on growth to late-stage private issuers with long-term growth potential, located primarily in, or with customers, suppliers or business primarily conducted in or dependent on, Canada and the United States. The firm's objective is to maximize its long-term capital appreciation by seeking to achieve superior risk-adjusted investment performance. The company was founded on April 1, 2021 and is headquartered in Toronto, Canada.

Stack Capital Group Inc

Stack Capital Group is attracting investor interest as an overlooked, low-float vehicle providing indirect exposure to major private assets like SpaceX and CoreWeave. The community is actively highlighting a perceived valuation gap between the firm's private portfolio holdings and its current trading price, positioning it as a potential alternative to more widely tracked space-themed investments.

Fox Corp. engages in providing television production and broadcasting services. It also provides news under the brands FOX News Media, FOX Sports, FOX Entertainment and FOX Television Stations, and Tubi Media Group. It operates through the following segments: Cable Network Programming, Television, and Other and Corporate. The Cable Network Programming segment refers to the production and licensing of news and sports content distributed primarily through traditional cable television systems, direct broadcast satellite operators, and telecommunication companies and online multi-channel video programming distributors. The Television segment focuses on the acquisition, marketing, and distribution of broadcast network programming. The Other and Corporate segment relates to the FOX Studio Lot, Credible Labs Inc, corporate overhead costs, and intracompany eliminations. The company was founded by Keith Rupert Murdoch on May 3, 2018, and is headquartered in New York, NY.

Fox Corporation - Ordinary Shares - Class A

Fox Corporation

Fox Corporation is currently drawing significant investor and community attention due to ongoing speculation regarding leadership succession and the company's broader strategic pivot toward digital and sports-centric programming. Community discussions are heavily focused on the evolving media landscape, particularly the impact of shifting consumer habits on traditional cable networks and the potential valuation shifts as the company seeks to monetize its digital platforms.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

AMGEN is trending due to anticipation surrounding its upcoming earnings report and investor interest in the late-stage development of its obesity candidate, MariTide. The community remains focused on how the company's established drug portfolio, including Repatha and Evenity, will balance potential pricing headwinds while navigating a competitive landscape for cardiometabolic treatments.

CVR Energy, Inc. is a holding company. The firm engages in the petroleum refining and marketing business. It operates through the following segments: Petroleum, Renewables and Nitrogen Fertilizer. The Petroleum segment refines and markets high value transportation fuels. The Renewables segment includes the operations of the renewable diesel unit. The Nitrogen Fertilizer segment markets nitrogen fertilizers primarily in the form of UAN and ammonia. The company was founded in September 1906 and is headquartered in Sugar Land, TX.

CVR Energy Inc

CVR Energy is trending as investors weigh significant operational setbacks, including recent refinery fires and power outages, against the potential for a rebound driven by high-profile insider accumulation from Carl Icahn. The community is actively debating the company's dividend sustainability and its long-term strategic value in a volatile energy market, with many focused on whether current share prices present an overlooked opportunity or a warning sign.

Hyperliquid is a performant L1 optimized from the ground up. The vision is a fully onchain open financial system with user built applications interfacing with performant native components, all without compromising end user experience.   The Hyperliquid L1 is performant enough to operate an entire ecosystem of permissionless financial applications – every order, cancel, trade, and liquidation happens transparently on-chain with block latency &lt;1 second. The chain currently supports 100k orders / second.  The Hyperliquid L1 uses a custom consensus algorithm called HyperBFT which is heavily inspired by Hotstuff and its successors. Both the algorithm and networking stack are optimized from the ground up to support the L1.   The flagship native application is a fully onchain order book perpetuals exchange, the Hyperliquid DEX. Further developments include a native token standard, spot trading, permissionless liquidity, etc.

Hype

Hyperliquid ($HYPE) is capturing significant attention as traders debate its long-term utility versus competitors like Aster and Avantis, while community discussions remain split between those bullish on its deflationary tokenomics and others wary of upcoming token unlocks. The conversation is heavily focused on HYPEs role as a dominant decentralized perpetual exchange, with investors closely watching its institutional volume growth and the potential for a broader market rotation into perp-DEX platforms.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is seeing significant community polarization, as long-term holders continue to emphasize long-term accumulation despite persistent price volatility and skepticism from traders questioning the lack of immediate upward momentum. The conversation centers on technical chart patterns and shifting macro indicators, with retail participants debating whether current levels represent a strategic entry point or a continuation of a downward trend.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Telix Pharmaceuticals Eyes 2026 Revenue Near $970M, Highlights PSMA Imaging Growth and Phase III Catalysts

Telix Pharmaceuticals (NASDAQ:TLX) executives highlighted commercial momentum in prostate cancer imaging and outlined multiple clinical programs in oncology during an H.C. Wainwright discussion featuring CEO Chris Behrenbruch and CMO David Cade.

Company overview and 2026 revenue outlook
Behrenbruch...

What Powers BWXT's Strength in Nuclear Medicine Manufacturing?

BWX Technologies expands beyond defense, boosting nuclear medicine with isotopes, new capabilities and a growing role in cancer diagnostics and treatment.

Telix Pharmaceuticals (NASDAQ:TLX) Trading Up 6.6% - Here's What Happened

Telix Pharmaceuticals (NASDAQ:TLX) Shares Up 6.6% - Time to Buy...

Telix Pharmaceuticals (NASDAQ:TLX) Rating Lowered to Sell at Wall Street Zen

Wall Street Zen lowered shares of Telix Pharmaceuticals from a "hold" rating to a "sell" rating in a report on Sunday...

Portland Investment Counsel Inc. Takes $1.23 Million Position in Telix Pharmaceuticals Limited $TLX

Portland Investment Counsel Inc. purchased a new position in Telix Pharmaceuticals Limited (NASDAQ:TLX - Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The...

Telix Pharmaceuticals Limited (NASDAQ:TLX) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Telix Pharmaceuticals Limited (NASDAQ:TLX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the nine brokerages that are currently covering the stock, Marketbeat.com...

Telix Pharmaceuticals (NASDAQ:TLX) Upgraded at Wall Street Zen

Wall Street Zen raised Telix Pharmaceuticals from a "sell" rating to a "hold" rating in a report on Saturday...

Telix Pharmaceuticals (NASDAQ:TLX) Stock Price Up 5.5% - Time to Buy?

Telix Pharmaceuticals (NASDAQ:TLX) Shares Up 5.5% - What's Next...

Telix Pharmaceuticals Highlights $1B Revenue Track, Pixclara Resubmission, PSMA Growth at Oppenheimer Conf.

Telix Pharmaceuticals (NASDAQ:TLX) outlined its commercial imaging franchise, regulatory plans for two radiodiagnostic candidates, and progress across a broad therapeutic radiopharmaceutical pipeline...

Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Up - Here's Why

Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Up - What's Next...

Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals. The Product Development segment develops radiopharmaceutical products for commercialization. It focuses on cancer care, specifically in prostate, renal or kidney and glioblastoma or brain cancer. Its products include TLX250, TLX591, and TLX101. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in Melbourne, Australia.

TLX
Telix Pharmaceuticals Limited American Depositary Shares

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TLX News

TLXTelix Pharmaceuticals Limited American Depositary Shares